About The OCRF
Established in 2000, the Ovarian Cancer Research Foundation is Australia’s leading independent body dedicated to ovarian cancer research.
By raising awareness and vital research funds, the Foundation can achieve their ultimate goal - to ensure an early detection test becomes readily available and habitual for every woman’s health regime.
Witchery’s donations of over $12 million have contributed to over 35 OCRF research projects and medical achievements across Australia in the past 10 years, including:
The appointment of dozens of specialised research scientists and research assistants.
Continuous funding of Andrew Stephens and his project team at the Hudson Institute of Medical Research since 2009.
The development of a potential early screening tool, the Active Ratio Test – clinical trials commenced in 2018.
The purchasing of equipment including a number of -180oC freezers and two -86oC freezers to store ovarian cancer tissue samples.
The acquiring of a Mass Spectrometer – a discovery tool for identifying specific protein profiles in bio fluids of ovarian cancer.
A Gel Spot Cutter – used to help cut gel spots containing protein for analysis in the Mass Spectrometer.
The White Shirt Campaign has been instrumental in helping fund expert research scientists, innovative projects and essential research equipment.
HUDSON INSTITUTE RESEARCHERS, THE MEN AND WOMEN ON THE FRONTLINE OF FIGHTING OVARIAN CANCER
About Ovarian Cancer
The cause of ovarian cancer remains largely unknown, while advances have been made in survival rates for breast and cervical cancers, there have been no recent breakthroughs in ovarian cancer, hence poor survival rates.
One woman dies every 8 hours from ovarian cancer in Australia
Approximately 1600 women are diagnosed with ovarian cancer every year
Vague symptoms like bloating and fatigue are often confused with other women’s health problems
The only way for a definitive diagnosis is by taking a tissue sample during surgery
Unlike breast and cervical cancers, there is no early detection test
Over 70% of diagnosed women will already be in the late stages, with the disease having spread to other parts of the body
75-80% of women diagnosed in the late stages will not survive beyond five years
Almost 90% of women diagnosed in late stages will see a recurrence within 2 years of treatment
Ovarian cancer is the leading cause of death of all gynaecological cancers
Witchery is proud to be one of the only leading Australian fashion brands to dedicate all gross proceeds of a collection to a charitable cause.
Join the fight, buy an OCRF white shirt today.Shop the collection